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Abstract
Ninety percent of cancer-related deaths are due to metastasis, hence improved
methods to understand and model metastasis are required. Current methods
of analyzing metastatic events in experimental animal models do not pro-
vide information on colony size distributions, and suffer from the inability to
segment micrometastases. Obtaining quantitative metrics in vivo would be
particularly useful in settings involving fluorescent cells, which are becoming
increasingly widespread for in vitro and in vivo applications, and are impor-
tant tools in identifying roles of specific proteins or genes in the metastatic
cascade. Quantification of metastatic colony size distributions would also find
applications in investigating clonal competition in genetically heterogenous
tumors and visualizing genetic exchange between cancer cells. Furthermore,
there are a limited number of mathematical models that describe metastasis
(as opposed to several that focus on tumor growth).
We have developed an image-processing based method, designed us-
ing MATLAB that effectively obtains quantitative data from fluorescent cell
colonies both in vitro and in vivo. The method is sensitive enough to segment
lung micrometastases consisting of only 4-5 cells, which makes it suitable
for mathematical modelling of cancer metastasis. The lower detection limit
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(compared to bioluminescence imaging or computational tomography, which
are often used to validate mathematical models), higher resolution and speed
of our method would assist in obtaining quantitative data for the purpose of
modelling.
Our methodology can also be applied to in vitro systems as well. While
clonogenic assays are often used to obtain growth potential, the assay de-
scribed in this work provides confluence, colony size distributions, colony-
forming potential and synergistic/ co-culture effects in fluorescently labelled
cells. Also, the method provides distributions of immunostained proteins of
interest between heterogenous cell populations, for instance the proliferation
marker ki67. The method is fast and accurate even for densely spaced colonies,
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Cancer metastasis is the term used to describe the dissemination of cancer
cells to distant organs from the primary tumor. Ninety percent of cancer-
related deaths are due to metastasis rather than due to the primary tumor, a
proportion that has not changed significantly over the last five decades [1].
Metastasis requires a series of interrelated events to take place, which are
described as the metastatic cascade. The following steps are involved: cancer
cell detachment from the primary tumor mass and invasion of the surrounding
tissue, intravasation into local blood or lymphatic vessels (i.e. the circulatory
system), extravasation through capillary beds at a secondary site, invasion of
the secondary organ and subsequent proliferation. Furthermore, tumor cells
may induce angiogenesis at the secondary site, form secondary metastases
(metastases of metastases), and evade the host immune system throughout
the cascade [2] [1].
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1.2 Experimental Analysis of Metastases
1.2.1 Mice Models
Experimental mouse models are a popular method of studying metastasis.
In order to study the metastatic process in such experimental models, the
ability to quantify the extent of the metastases is needed. However, current
methods of quantitatively analyzing metastases in vivo do not provide suffi-
cient quantitative information pertaining to metastatic colonies or their spatial
distributions at the organ-level [3].
1.2.2 Hematoxylin & Eosin Staining
Traditionally, Hematoxylin & Eosin (H&E) stained tissue sections have been
used to visualize metastatic regions in organs. To obtain quantification of
metastases in lungs, the following simplified procedure is used. After sacri-
ficing the mouse, most of the rib cage is removed and the lungs are inflated
by gently injecting with 4% Paraformaldehyde (PFA). Next, the lungs and
heart are removed, submerged in PFA and embedded in paraffin after which
H&E staining is carried out. After the paraffin-embedded tissue sections are
mounted on slides, they may be scanned such that the whole tissue section
is captured digitally. Software programs such as ImageJ, NIS-Elements and
CellProfiler exist that calculate overall tissue area based on freehand selection
(which provides us a measure the total tissue area). Finally, areas containing
metastatic cells are identified and traced manually. If fluorescent markers
are being used, the fluorescent regions may be identified by binarization,
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i.e. converting pixel intensities into binary true/false, gated according to a
threshold. The threshold can be set manually or an optimum threshold may
be obtained by an algorithm, such that true fluorescent pixels are accepted
and pixels containing autofluorescence or background signal are not.
From the above exercise it is possible to get total metastatic area, number
of metastases, total tissue area, and hence average area of each metastasis
as well as the density of metastases in lung tissue. Region-Of-Interest (ROI)
tracing on sections can provide an estimate of individual metastatic colony
sizes . However this is highly labor-intensive and time consuming, especially
when dealing with high metastatic loads and a large number of sample im-
ages. Furthermore, the user has to visually judge what regions constitute a
’metastasis’, taking care to avoid regions of immune infiltration and regions
around blood vessels or bronchioles, which exhibit higher packing density
and might appear similar to tumor cells [4].
1.2.3 Quantitative Polymerase Chain Reaction
Quantitative polymerase chain reaction (qPCR) is another tool that is used
to quantify overall metastatic burden in organs, and has been applied to
both xenograft and syngeneic experimental models. In xenograft models,
where human tumor cells are transplanted onto a host belonging to a different
species, detection and quantization of human alu sequences from host organ
DNA extracts is the basis for quantifying metastatic load [5–7]. In syngeneic
models this method cannot be used since the tumor and host cells have the
same genome. For syngeneic models, a recent study introduced a modified
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luciferase gene (Luc2) into tumor cells using a lentivirus. By using a primer
designed for amplifying a luciferase gene fragment, it was possible to quantify
Luc2-positive tumor cells, with a sensitivity of one tumor cell per 10,000 [3].
Another study showed that it is possible in certain cell lines to quantify
metastatic load in syngeneic models using qPCR based on differences in
expression of signature genes between metastatic cells and normal cells [8].
While qPCR based methods are sensitive and can measure metastatic loads
in a host organ, they require homogenized tissues, or tissue extracts, and
hence no information on metastatic colony sizes is obtained.
1.2.4 Bioluminescence Imaging
Bioluminescence imaging (BLI) is a popular method of quantifying tumor and
metastatic loads based on measuring fluorescence values. Cancer cells are
genetically modified to express the enzyme luciferase before being introduced
into the animal. Subsequently, at a suitable time point, the substrate, lu-
ciferin, is injected in the animal. Upon coming into contact with the substrate,
luciferase-expressing cancer cells emit photons through the luciferase protein
reaction. ’Luciferin’ and ’Luciferase’ are general terms for the substrate and
enzyme which react to produce light emission in bioluminescent organisms.
For research applications the most commonly used enzyme/substrate pair
is the one present in the male firefly Photinus pyralis. Mice are injected with
luciferin prior to imaging, and are imaged using a Xenogen imager.
While it requires an expensive substrate and specialized imaging equip-
ment, an advantage of BLI is that it is a dynamic assay and can be conducted
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over time, with mice anaesthetized before every measurement, making it suit-
able for visualizing tumor progression and metastasis. While BLI is suitable
for qualitative or yes/no applications, it does not allow true quantification of
the target signal. This is because the signal depends on a variety of factors
aside from luciferase expression, such as depth, and local concentrations of
luciferin, ATP and oxygen. Furthermore, any signal received is significantly
weighted towards the surface due to the rapid signal attenuation that occurs
as the photons pass through tissue [9, 10].
1.3 Mathematical Modelling of Cancer
1.3.1 Overview
Mathematical modelling of cancer has been on the rise in past years and
has proved to be an important tool in understanding the disease. Mathe-
matical models have been employed to shed light on different processes in
tumor growth, suggest treatment options, devise experiments and re-evaluate
prognoses [11]. Mathematical models are useful for integrating disparate
experimental data, in order to understand the overall process of cancer pro-
gression. Since experiments are usually designed with a narrow focus, limited
to one or few steps of tumor growth and the metastatic cascade, it falls on
mathematical models to provide higher level insights of these processes. How-
ever, as of today, modelling has been mostly limited to primary tumor-growth,
as opposed to metastasis [12].
Several models have been proposed to predict tumor growth and dynamics,
from the earliest ones that were used as predictors of tumor size, to those
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that attempt to model the various effects of signal transduction pathways. Of
the former kind, the phenomenological Gompertz model has remained most
popular despite its empirical nature, due to its accurate prediction of tumor
size and ease of application to different data sets [13]. Recent approaches
involve developing models that account for the effects of various factors
involved in tumor cell growth, such as the microenvironment, vasculature
and angiogenesis, the impact of therapeutics, and cancer stem-cells [14–18].
1.3.2 Modelling Cancer Metastasis
Modelling metastatic processes is a challenge due to the complexity of the
metastatic cascade, hence while several models exist that predict tumor growth
or model interactions that occur in the tumor microenvironment, fewer have
been developed, especially recently, that predict metastatic spreading [11, 19].
One of the motivations for a predictive model for metastasis is to obtain
metastatic colony size distributions. Specifically, to estimate the formation
of micrometastases that are only a few cells large, and which are below the
detection limit of clinical diagnostics.
One study developed a deterministic, dynamical model to obtain the size
distribution of metastases, and validated it using colony size measurements
obtained by computed tomography (CT) scans of a patient with hepatocellular
carcinoma before and after therapy. It was discussed that quantitative predic-
tion of metastatic colony size distribution is important in the clinical setting
since colony sizes and vascularity, both of which are estimated by the model,
play a role in determining the effects of chemotherapy [20]. The same model
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was fitted on data obtained in a follow-up study that examined 3,500 patients
for metastatic relapse, and it was found to accurately predict metastatic risk.
This follow-up study, while demonstrating the reliability of the former model,
provided no information about the growth dynamics of the metastases [21]. .
Similar to the deterministic model cited above, some stochastic models
have been developed that predict the state of micrometastases present in the
patient, by modelling the colony size distributions in the patient at a given
time. [22–24]. Such patient-specific data is unavailable to clinicians at this
time, and represents a step toward having personalized information of the
disease [12]. While powerful, these studies are based on a single patient
and involves cancer progression in a single organ, hence a more rigorous
validation would seem to be the next logical step.
A more recent study attempted to perform such a rigorous validation
using an orthotopic xenograft in mice. It is logical to use animal experiments
for model validation since obtaining the equivalent data clinically would be
difficult due to ethical reasons and the long time scales involved in cancer
progression. In this study, quantification of metastatic spreading over time was
done using in vivo 3D Bioluminescence Imaging (BLI). Due to the limitations
of BLI discussed in the previous section, the experimenters could measure
only the tumor size and total metastatic load, with no quantification of the
individual metastatic foci or their impacts on metastasis. Another concern
is that the BLI measurements were calibrated by obtaining an in vitro cell-
to-signal ratio, which represents a source of experimental error, since signal
attenuation through mouse tissue and variation of the luciferase reaction
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between different organs of the host (as discussed previously) may affect the
experimental (in vivo) cell-to-signal ratio [19].
1.4 Fluorescent Cells And Cancer Research
Fluorescent proteins, such as the Green Fluorescent Protein (GFP) and other
related proteins, do not require substrates or cofactors to emit light due to the
presence of internal chromophores. Cells expressing or tagged with fluores-
cent proteins have found many different applications in cancer research over
the past two decades [25].
In one study fluorescent proteins were used to visualize in vivo genetic
exchange between prostate cancer cells, and it was observed that this led to
enhanced metastatic capability. Two parental cell lines were used in this study,
separately expressing GFP and RFP. Cells that had undergone genetic ex-
change expressed both proteins and appeared yellow [26]. The same lab used
this principle to investigate metastatic clonality in other cancer cell lines [27].
A similar study was performed with a high metastatic and a low metastatic
human osteosarcoma cell line showed an increase in metastatic potential in
the low metastatic cell line when co-transplanted with the high metastatic
cell line, but not when transplanted separately. The system was color-coded
similar to the one described above, which enabled the experimenters to de-
termine the origin of metastatic colonies in the host organs [28]. Aside from
clonality, a dual-colour fluorescence based imaging system has also been used
to investigate stem-cell like behaviour in cancer cell lines [29].
Fluorescent proteins have been used in several ways to visualize cells and
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their behaviour in mice via the creation of transgenic mice. Furthermore,
transgenic reporter mice have been developed which are able to label specific
cellular characteristics, such as gene expression or cell cycle progression [30].
For example, a reporter mouse expressing GFP-tagged β-actin, controlled by
a keratin-14 (K14) promoter was generated [31]. This allowed visualization of
K14+ tumor cells that coexpressed an mTomato reporter construct. [32]. The
tool described in this work can be used to investigate and quantify metastatic
potential, growth and colony formation of the K14+ cells versus K14- cells both
in vivo and in vitro. In an interesting study, a Cre-based fluorescent reporter
system was developed that changed color upon epithelial-to-mesenchymal
transition [33]. Cells which had undergone EMT were found to be more likely
to lead to early metastatic events, and were more resistant to chemotherapy.
In this study, overall metastatic loads and the fractional contributions by the
dual colored cells were reported. The assay described in this work could be
applied to this system to obtain colony level data in vivo and in vitro.
1.5 In Vitro Clonogenic Assay
The clonogenic assay was first described in 1956 in an experiment that ana-
lyzed the effect of x-rays on the colony-formation ability (clonogenicity) of a
human cervical carcinoma cell line (HeLa cells). In the clonogenic assay, cells
are fixed and stained by crystal violet, and counted manually [34]. The x-ray
dose/ survival curves obtained from this assay (obtained by counting the
number of viable colonies) represented a quantification of the cytotoxic effects
of ionizing radiation. Since then the assay has been modified and applied to a
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number of experiments and is currently a widely-used experiment for cancer
biologists [35]. Some computational tools have been developed for the assay,
for statistical analyses [36] and automated colony segmentation [37]. While the
clonogenic assay can quantify differences in sensitivity to cytotoxic agents, it
is not suitable for co-culturing different cell lines and cannot visualize proteins
of interest. Also, since the assay involves crystal-violet staining, automated
segmentation algorithms are based on colony area as opposed to cell count
(although the discrepancy between the two counts is mitigated by taking into
account the intensity of the stain).
1.6 Digital Pathology and Image Processing
Digital pathology has gained increasing importance over the past decade
with increases in computational power and the advent of sophisticated image
analysis techniques. While traditional visual microscopy based pathology
is the current gold-standard, it can be prone to lack of standardization or
variation between pathologists [38, 39], and is time consuming [40]. These
are the principal issues which digital pathology seeks to overcome. While
digital pathology is slowly gaining relevance in the clinical setting, there are
some technical issues which remain to be tackled [41–43]. For example, three-
dimensional cell clusters or dense smears make digital pathology difficult [44].
In research applications involving fluorescently labelled cells, some of the
limitations encountered in the clinical setting do not apply. Fluorescently
labelled cells are a popular choice in vitro and are becoming increasingly
widespread in cancer research for in vivo experiments (as described in the
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previous section). From a digital pathology point-of-view, these cells have
an advantage in that they are easier to identify and can be segmented into
colonies with greater ease than clinical specimens stained with colorimetric
dyes such as H&E. This facilitates the application of image analysis techniques
in obtaining quantitative data from histological sections.
1.7 Motivation
The methodology described in this work to analyze experimental metastases
provides sharper, more granular data than existing techniques. So far, there
has been no effort in quantifying metastases at the colony level, partly due
to the lack of sensitive enough methods. However, images obtained through
fluorescence microscopy are suitable for image analysis techniques to quantify
information directly from fluorescence micrographs with speed and accuracy.
There is a need for experimental metastatic data for creating and vali-
dating effective mathematical models of cancer metastasis, of which there
are currently few available. Presently, experimental data for mathematical
models is obtained from BLI or similar methods, which provide no data at the
colony level. Furthermore, this methodology would be useful for quantifica-
tion and modelling of synergistic/ non-autonomous effects, and investigating
clonal competition in cancer cell lines, both in vitro and in vivo. The in vitro
assay has the advantage of being fast and experimentally simple, while giving
quantitative information on proliferation, dynamics of colony formation and
protein expression over time, while identifying co-culture effects, in a single
experiment.
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Finally, with the popularity of transgenic reporter mice and fluorescent
cells reporting expression of proteins- or genes-of-interest, we require a fast
and simple way of quantifying differences in proliferation, colony formation
and metastatic potential of different cell lines.
In our lab, the in vivo methodology was used to obtain differences in
metastatic colony size distributions of MDA-MB-231 tumor cells. The tumor
cells used contained a Hypoxia Inducible Factor (HIF) - regulated reporter
plasmid construct, a sequence that causes the cell to permanently switch from
expressing DsRed to GFP upon exposure of the cell to hypoxia in the primary
tumor (unpublished work). Hence, upon the onset of tumor hypoxia, a portion
of the tumor cells shift from expressing DsRed to GFP, which in turn leads to
metastatic colonies in mice organs which are either DsRed+ or GFP+. Using
our tool, we identified and quantified differences in size distributions between





MCF7 and MDA-MB-231 cells were cultured in Dulbecco’s Minimum Essential
Media (DMEM) (Sigma-Aldrich, St. Louis MI - USA) supplemented with
10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin (Invitrogen,
Carlsbad) in a humidified atmosphere of 5% CO2 at 37°C.
2.2 Fluorescent Cell Lines
MDA-MB-231 and MCF-7 cell lines DsRed- and GFP- expressing were gener-
ated by transfecting them with two independent lentiviral vectors. Vector 1
expresses a DsRed reporter with a stop codon flanked by tandem loxP sites
(’floxed’) and located in front an GFP gene. In the absence of Cre-recombinase,
cells express a red fluorescent protein (DsRed) as shown in figure 2.1A. DsRed-
expressing cell lines were transfected exclusively with vector 1. Deletion of
DsRed by Cre recombinase results in the rapid loss of DsRed and the perma-
nent activation of GFP expression. Vector 2 expresses the Cre gene under the
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control of the constitutively activated U6 promoter and CMV enhancer (figure
2.1B). GFP-expressing cell lines were generated from the existent DsRed-
expressing cells after transfection with vector 2. All cell lines were sorted
using a SH800 Cell Sorter in sterile conditions, to guarantee purity and high-
fluorescence.
To generate a hypoxia-reporter system, MDA-MB-231 cells already trans-
fected with vector 1, were then transfected with vector 3. Vector 3 expresses
the Cre gene under the control of a synthetic hypoxia reporter which was
designed based on the putative HIF-binding sequence. Under hypoxic con-
ditions, HIFs will drive the expression of Cre to excise the DsRed coding
sequence in vector 1 (2.1C and D).
2.3 In Vitro Colony Formation Assay
2.3.1 Plating
DsRed-expressing cells (DsRed+) and GFP-expressing cells (GFP+) were used
in our experiments. To model cell lines with different proliferation rates and
clonogenicity, GFP+ cells were cultured in media containing 2 nM Paclitaxel
for 48 hours prior to plating for the in vitro experiment, whereas DsRed+ cells
were cultured in normal media. Following this, 2000 each of DsRed+ and
Paclitaxel-precultured GFP+ cells were added to three wells of a 6 well-plate,
for a total of 4000 cells per well, and grown in normal media with standard
tissue culture. To the remaining three wells of the well-plate, 2000 each of
DsRed+ and untreated GFP+ cells were added, to function as a control.
14
Figure 2.1: A:Vector 1 expressing floxed DsRed. This system is present in DsRed+
cells. B: Vectors 1 and 2. The action of vector 2 results in DsRed cleavage from vector
1. This system is present in GFP+ cells. C: Vectors 1 and 3 under normoxia. D: Vectors
1 and 3 under hypoxia, resulting in DsRed cleavage.
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2.3.2 Live-cell vs. Fixed-cell Modes
We designed two modes of operation for the in vitro colony formation assay -
live-cell and fixed-cell. The fixed-cell mode is an end-point assay that involves
fixing with paraformaldehyde and allows for immunostaining of proteins of
interest. The live-cell mode allows the user to observe and quantify colony
growth in a given plate continuously over time. A full comparison is provided
in the subsequent sections.
2.3.3 Fixing and Staining
This section applies to the fixed-cell mode only. A 6 well-plate was fixed at
each time point and stained for Ki-67 as follows.
1. Culture media was removed
2. Cells were fixed by adding 4% paraformaldehyde (PFA) in phosphate-
buffered-saline (PBS) for 15 minutes.
3. Triton-X (1%) was added for 5 minutes.
4. Bovine serum albumin (2% in PBS) was added for 30 minutes.
5. Immunostaining was performed with anti Ki-67 monoclonal antibody
(Alexa Fluor 647 Mouse anti-Ki-67, BD Biosciences) for 90 minutes.
6. Nuclear staining was performed with a 5µg/mL Hoechst 33342 solution
in PBS, for 15 minutes.
All wells were washed in PBS after each step. Fixed and stained cells were
stored at 4◦C under PBS.
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2.3.4 Imaging
Plates were imaged using a Cytation 5 imaging reader (BioTek, Winooski, VT,
USA) equipped with an incubated stage. For the live-cell mode, the stage was
maintained at 37◦C, and images of the same plate, at the same position were
obtained in the RFP and GFP channels at timepoints of 1, 2 and 4 days. For
the fixed-cell mode, separate plates prepared on day 0 were imaged under
RFP, GFP, DAPI and CY5 channels on days 2, 4 and 5.
Plates were imaged at a magnification of 4x. A montage of images was
used to cover approximately 80% of the well area, which provided a sufficient
number of colonies to obtain size distributions. The images were stitched with
NIS Elements software(Nikon Instruments Inc., Melville, NY, USA) and their
dimensions reduced to 50% in order reduce processing time.
2.4 Image Processing and Analysis - In Vitro
2.4.1 Introduction
In this section we discuss the image-processing filters and algorithms used in
obtaining quantitative data from the in vitro images generated in the previous
section. All scripts were created in MATLAB 2017b (MathWorks Inc., Natick,
MA, USA), using the Image Processing Toolbox available for MATLAB. The
image processing steps of the fixed cell mode is summarized in figure 2.3,
and described in detail in the subsections below (from 2.4.2 to 2.4.6). The
algorithmically simpler live-cell mode is discussed in subsection 2.4.7. A
flowchart of the steps involved is provided in figure
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Figure 2.2: Flowchart of the image processing scheme employed in the in vitro experi-
ment.
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The script loads the RFP, GFP, DAPI and CY5 images generated in the
imaging step in the fixed-cell mode and performs the operations described
below.
2.4.2 Preprocessing
Figure 2.3 A: On the DAPI (and as well as the RFP and GFP) images, as a
background correction step, top-hat filtering is used. This reduces background
fluorescence, signal due to bubbles and lens artifacts. Gaussian filtering is
used to eliminate jagged boundaries an obtain smooth colony-regions. A
final contrast adjust step ensures that the fluorescent regions are above the
threshold of segmentation. The results of the preprocessing steps are shown in
Figure 2.4. After this step, the image is binarized.The binarized DAPI image
identifies pixels that are occupied by cell colonies (as opposed to background).
2.4.3 Distance Transform
Figure 2.3 B: In the binarized image obtained in the previous step, a given pixel
has the value ’1’ if it lies within a colony and ’0’ if not. A distance transform
is then performed on the complement of the binary image, which effectively
replaces the value of each pixel within a colony with the Euclidean distance
to the nearest boundary. This image was inverted (dark regions were made
bright and vice versa), and the background was made bright. The results
of this treatment are shown in Figure 2.5. Observe the dark regions at the
centres of each colony, which function as catchment regions for the watershed
segmentation step mentioned below.
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Figure 2.3: A: Nuclear staining (DAPI channel). B: Preprocessing steps and distance
transform identifies watersheds. C: Segmentation of colonies by watershed algorithm.
D: Individual colonies analyzed. E: DsRed and GFP signal captured in RFP and GFP
channels respectively. F: DsRed+/GFP+ regions obtained by preprocessing steps and
binarization. G: Segmented colonies classified as DsRed+/ GFP+ based on input
from images F1 and F2. G: Cell count and area of individual colonies obtained from
colony-level DAPI image. I: Ki-67 image in CY5 channel. J: Regions expressing Ki-67
obtained by binarization. K: Distribution of Ki-67 coverage, colony sizes obtained
separately for populations of DsRed+ and GFP+ cells. Scalebars: 5 mm (A, E, I, J), 1
mm (G, I)
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Figure 2.4: A: Raw stitched image obtained from plate reader. B: Image after prepro-
cessing (top-hat filtering, gaussian filtering and contrast adjustment)
Figure 2.5: A: Raw stitched image showing one colony. B: Distance Transform applied
and inverted.
This method takes advantage of the fact that in vitro colonies are roughly
circular. We use an h-minima transform to suppress small minima which
otherwise lead to oversegmentation.
2.4.4 Watershed Segmentation
Figure 2.3 C: The watershed transform is a popular method for image seg-
mentation. The algorithm views the subject image as a topographical map,
viewing bright pixels as ’high’ and dark ones as ’low’. It segments the image
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into catchment areas based on dark ’basins’, which are then used as foci for
segmenting objects corresponding to each basins [45, 46]. In our application,
we use a distance transform to obtain ’high’ or bright regions, invert them so
that they become ’basins’, and subsequently use them as foci for segmenting
colonies in vitro. An example of the segmentation step is provided in figure
2.6, where a large group of connected colonies is accurately segmented into
individual colonies. While the script works well with clustered or partially
overlapping colonies, it cannot distinguish sheet-like areas or areas where
multiple colonies have fused into a ’super-colony’, which is also shown in the
figure.
Figure 2.6: A: A group of connected colonies. B: Successful segmentation by water-




Figure 2.3 D, H: The segmentation step provides us colony sizes. Furthermore,
individual nuclei in with each colony are counted (algorithmically) based
on the signal received from the nuclear-stained cells. The algorithm for seg-
menting nuclei closely resembles the colony segmentation step in that it also
involves a distance transform followed by a watershed algorithm. Hence, the
fixed cell assay provides colony cell counts as well as areas. The results of the
segmentation can be seen in figure 2.7A-C.
Furthermore, based on input from the RFP/GFP channel images, seg-
mented colonies may be classified as DsRED+ or GFP+, which is shown in
figure 2.3 E-G. The signal from binarized GFP/RFP images determine whether
a given colony (segmented in the previous steps) consists of pixels that are
GFP+ or DsRed+, which is the basis for classifying colonies based on origi-
nating cell line. Hence, distributions of colony areas and cell counts can be
obtained from each of the two populations (DsRed+ and GFP+), and quantita-
tive differences between them may be analyzed.
2.4.6 Ki-67 Analysis
Figure 2.3 I-K: The fixed-cell assay enables the experimenter to obtain distribu-
tions of immunostained proteins of interest. In our assay we use the protein
Ki-67 as an example, stained by an antibody that fluoresces in the CY5 channel.
More detailed steps involved in obtaining nuclei which are positive for ki-67
in each colony are represented in figure 2.7.
Since Ki-67 is a nuclear protein, we require DAPI-stained nuclei (figure 2.7
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Figure 2.7: A: DAPI channel image of nuclear-stained colony. B: Binarized colony
image. C: Segmentation of nuclei based on distance transform and watershed seg-
mentation. D: CY5 channel image showing immunostained Ki-67. E: Binarized Ki-67
image showing Ki-67+ regions. F: Histogram of colony nuclei binned by fractional
Ki-67 nuclear staining. All nuclei with more than 25% Ki-67 staining are marked
’Ki-67 positive’.
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A). The nuclei are segmented using a distance-transform followed by water-
shed algorithm, similar to the scheme described previously for segmenting
whole colonies (figure 2.7 B, C). The pixels constituting each nucleus are com-
pared with those (at the corresponding location) in the binarized Ki-67 image
(figure 2.7 E). Thus the fraction of total pixels (or area) positive for Ki-67 are
obtained for each nucleus. If this fraction is greater than a fixed arbitrary
threshold (which is 0.25 in our assay, as shown in figure 2.7 F), the nucleus
is considered to be positive for Ki-67. Thus, we can obtain the fraction of
cells that express ki-67 in each colony. The distribution of this metric can be
obtained for the entire population, and differences between cell-lines can be
analyzed.
2.4.7 Image Processing Steps in Live-cell Mode
The live-cell assay has the advantage that it requires fewer materials, no
sample preparation and lesser imaging time as compared to fixed-cell mode.
It is a dynamic assay, which allows colony growth to be modelled over time.
Since there is no nuclear staining or immunofluorescence staining, only the
fluorescent markers present in the cell-line ab initio are imaged - in our case,
DsRed and GFP, imaged in the RFP and GFP channels.
The image processing scheme followed is similar to the fixed-cell mode
in that we again employ a distance transform to identify ’basins’, which
are used to segment colonies by applying the watershed algorithm. The
difference lies in the channels to which the segmentation step is applied. In
the fixed-cell mode, images displaying nuclear staining, obtained the DAPI
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Figure 2.8: A,B: RFP/GFP channel images after preprocessing. C: Individual channels
segmented by distance transform, watershed algorithm, and the results are combined.
D: Colony metrics are obtained for each channel. E: Distributions of colony metrics
are plotted together for comparison between cell lines.
channel, are used to identify individual colonies, and signal from the RFP/GFP
masks enables classification of each colony as ’red’ or ’green’. In the live-cell
mode, we directly segment colonies using images obtained from the RFP/GFP
channel (i.e. displaying the native DsRed/ GFP fluorescence of the cell-lines
being used).
This effectively means that the colonies are already ’sorted’ by cell line
(’red’ and ’green’), and the function of the algorithm here is to accurately
segment individual colonies and quantify their size, area or intensities as may
be required. The live-cell scheme is shown below in figure 2.8.
2.5 Animal Study
Female 5- to 7-week-old NSG mice were used according to protocols approved
by the Johns Hopkins University Animal Care and Use Committee. Mice were
anesthetized, and 2 × 106 MDA-MB-231 cells were injected into the mammary
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fat pad (MFP) in a 1:1 ratio of DsRed- and GFP-expressing cells. In another
experiment, 5 × 104 MDA-MB-231 cells were directly injected into the tail
vein, in a mix of 1:1 DsRed- and GFP-expressing cells. After 3 weeks, the
mice were sacrificed and the lungs were inflated with a solution of PBS:OCT
(Optimal Cutting Temperature Compound, Fisher Healthcare, Pittsburgh, PA,
USA), harvested and immediately fixed in 10% neutral buffered formalin for
1 hour, followed by an overnight soak in 30% sucrose solution at 4 degrees.
The lungs were then frozen in OCT and cryo-sectioned into 15 um slices, that
were immediately stored at -20°C.
2.6 In Vivo Metastatic Colony Formation
We developed an algorithm to obtain colony size distributions from fixed
and stained tissue sections, based on similar principles to the in vitro assay
described earlier.
2.6.1 Tissue Sections
Tissue slides were washed 3 times in a PBS-T solution (1% Tween in PBS 1X).
In the dark, Sudan Black 0.1% was used for 25 minutes at room temperature
to reduce tissue background fluorescence. After another similar washing step,
the tissue slides were stained with DAPI (1:1000 in PBS) for 15 minutes at room
temperature. After washing, the slides were mounted with a 90% Glycerol




Similar to the in vitro imaging step, slides were imaged at a magnification
of 4x in the DAPI, GFP and RFP channels. A montage of images was used
to cover the entire lung section on the slide, and the images produced were
stitched using Gen5 (BioTek). The stitched images were reduced to 50% in
size in order to facilitate processing.
2.7 Image Processing and Analysis - In Vivo
2.7.1 Introduction
Once the slides containing lung sections have been digitized, we can apply
the image processing scripts developed in this work to obtain quantitative
data from them. The full in vivo algorithm is given in figure 2.9. Identical
treatement is performed for the RFP and GFP channels. The algorithms
is divided into two parts - Part 1 segments all metastatic colonies except
micrometastases, which are eliminated during the blurring step. Once the
large colonies are segmented, they are masked and the remaining area is
scanned for micrometastases, i.e. seeding events which are only a few cells
large in size. Any such events that are within an arbitrary distance of 40
pixels from the large metastatic colonies are rejected, since we cannot know
whether such a colony has been seeded from a primary tumor or represents
cells migrating from the nearby metastatic colony in the organ. The DAPI
channel is only used to identify lung regions from background and plays no
role in the segmentation steps.
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Figure 2.9: A: Overall scheme for segmenting colonies from tissue sections B: Flow-
diagram showing steps involved
2.7.2 Preprocessing
The preprocessing steps consist of gaussian filtering and contrast adjustment.
The parameters of both these filters are modified for each set of experiments
to give reasonable segmentation. The gaussian filter removes micrometastases
and retains the general shape of the original colonies.
2.7.3 Extended-Maximum Transform
Since the lung metastatic colonies are not circular, segmentation based on the
distance transform. Hence, the extended-maximum transform is used to iden-
tify local maxima - which are regions of densely packed cells - in metastatic
colonies, which serve as the foci (’basins’/ ’troughs’) for the watershed algo-
rithm. A similar method has been discussed for other applications in existing
literature [46]. The segmentation is accurate for regions of dense colonies as
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Figure 2.10: A: Region of lung with dense metastases B: Segmented large metastases
shown in figure 2.10. A simple threshold based segmentation step is unable to
distinguish between adjacent metastases.
2.7.4 Micrometastases Segmentation
Once the larger metastatic colonies have been segmented, the intensities of
all pixels that either constitute a metastatic colony (in either the RFP or GFP
channel) or lie within 40 pixels of a metastatic colony, are reduced to zero. The
resultant image only contains micrometastases that are reasonably far away
from large metastatic colonies. Micrometastases are segmented with a simple
binarization step. Artifacts due to debris or autofluorescence (due to traces of
blood) were observed as bright spots positive in both GFP and RFP channels.
These are eliminated by removing pixels that were positive in both GFP and
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RFP channels after binarization.
2.8 Statistical Analysis
Differences in colony sizes were verified through a Wilcoxon Rank Sum test,
and distributions were analyzed by the Kruskal-Wallis test. Both tests were
evaluated through functions available in MATLAB or GraphPad Prism (Graph-




3.1 Proliferation Study of DsRed+ and GFP+ Cells
This chapter contains two sections, one each for discussing in vivo and in vitro
results. Before carrying out the in vitro colony formation assay, we determined
that there was no significant difference in the growth rates of our fluorescently
labelled MCF7 cell lines by trypsinizing and counting cells in a hemocytometer
over an 11 day time course, shown in Figure 3.1.
3.2 Colony Segmentation and Analysis In Vitro
The experimental methods and image processing algorithms used to quantify
data have been discussed in the previous section. GFP+ (Green, pretreated)
cells were treated with paclitaxel and co-cultured with DsRed+ cells (Red,
untreated). As a control, untreated GFP+ and DsRed+ cells were co-cultured
(Red, Green).
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Figure 3.1: No significant differences in proliferation rates were observed
3.2.1 Live-Cell Mode: Monitoring Colony Areas
The live-cell mode is a quick and simple method that can be used to follow
individual colony growth visually and monitor colony size distributions over
time. The same plate can be imaged repeatedly at different time points and
colony size distributions obtained. The results are shown in figure 3.2.
The total area of all the colonies can be used as a measure of confluence or
proliferation of the given cell line, as shown in figure 3.2 A. Cells that had been
treated with paclitaxel before plating show significantly reduced proliferation
(P<0.001) over the experiment. The cell-line treated with paclitaxel prior to
drug treatment produced smaller colonies. The colony size distribution of
drug treated cells was significantly different (P<0.001) than those of cells
without drug treatment, in co-culture or in control wells. There was no
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Figure 3.2: A: Fold change in sum of colony areas. B: Statistical analysis of colony
size distributions on day 04, across all wells by the Kruskal-Wallis test. GFP+ cells,
which were pretreated with paclitaxel prior to plating are observed to produce sig-
nificantly smaller colonies, as opposed to the DsRed+ cells in co-culture. Control
wells, where neither cell lines were pretreated show identical colony size distributions.
C: Histogram showing difference in colony size distribution for DsRed+ (red) and
pretreated GFP+ (green) cells, obtained from one well of a six well plate. Inset figure
shows results from control well. D: Normalized histogram and probability density
function of colony size distributions from drug-treated and (inset) control well.
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Figure 3.3: The probability density functions of colony sizes as they change over the
duration of the live cell experiments. Mean and standard deviations of probability
distributions functions are shown.
significant difference between the distributions of cells untreated with drug
(figure 3.2B). Figures 3.2 C and D show size distributions from a single well of
a six well plate, showing counts and probability densities respectively. The
shift of the GFP+ histograms to the left clearly indicates smaller mean and
median colony size. The DsRed+/ GFP+ histograms from control wells are
indistinguishable. The probability density functions averaged over all wells,
as they change over time, are showed in figure 3.3.
3.2.2 Correlating Colony Areas with Cell Counts
An important difference between the live-cell and fixed-cell modes of the
in vitro experiments is that colony size is measured only in pixels (and not
number of constituent cells) in the live-cell mode. This limitation arises
from the difficulty in segmenting closely spaced cells displaying cytoplasmic
staining. However, obtaining cell counts by segmenting nuclei is possible.
This means that in the fixed-cell mode, which contains a nuclear-staining step,
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the experimenter may obtain colony cell counts.
Figure 3.4: Correlating colony areas to cell counts.
Nuclei are segmented using a distance transform combined with a water-
shed segmentation step - similar to the algorithm used to segment individual
colonies in the fixed-cell mode of the in vitro assay. It is then possible to obtain
a correlation between colony area and cell count. Once this correlation is ob-
tained for a given cell line, it could be applied to any live-cell experiments that
may be performed, allowing the experimenter to obtain estimates of colony
cell counts.
3.2.3 Fixed-cell Mode: Monitoring Colony Cell Counts and
KI67 distribution
The methods involved in carrying out fixed-cell assays have been discussed
previously. Similar to the effect observed in the live-cell assay, the leftward
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shift in colony size distributions under effect of paclitaxel is observed in the
fixed cell mode too, as shown in figure 3.5A. The image analysis scheme to
investigate Ki-67 distributions have been discussed in the previous chapter.
In the fixed-cell in vitro assay, we observed paclitaxel-treated cells to have a
larger fraction of non-proliferating or low-Ki-67 colonies 3.5B.
The microscope images obtained through the fixed-cell assay on day 04
are shown in figure 3.6.
3.2.4 Validation of MATLAB tool with manual thresholding
Colony size distributions were obtained through ImageJ and compared with
the results obtained by our MATLAB script. In ImageJ, binarizing RFP and
GFP channel images obtained from the live-cell experiment, and analyzing
all objects so obtained provided colony size distributions. While discrete
colonies are segmented fairly accurately in ImageJ (or by any other simple
thresholding method), connected colonies are not. Furthermore, this process
needs to be repeated for every well and is time consuming as compared to our
algorithm. Manual tracing of colonies would ensure accurate segmentation
even for dense or connected colonies, but the amount of experimenter time
taken is large (more than 20 minutes per well). Analyzing in fixed-cell mode,
with nucleus counting and ki-67 evaluation is even more difficult and time
consuming in ImageJ.
In figure 3.7, we compare colony size distributions obtained from the
MATLAB tool described in this work and ImageJ binarization/object counting,
from a single well of a 6 well-plate. While the overall shape of the distribution
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remains the same, ImageJ shows elevated numbers of large colonies, probably
due to inaccurate segmentation of connected colonies.
3.3 Colony Segmentation and Analysis In Vivo
Two experiments are discussed in this section. The first is an orthotopically
transplanted tumor containing cells with the hypoxia-reporter construct. The
second is a tail-vein injection of an equal mixture of DsRed+ and GFP+ cells.
The details of the model and the methods involved in slide preparation and
the image processing scheme to quantify metastatic colony sizes in vivo have
been discussed in the previous chapter.
3.3.1 In vivo colony size distribution differences in hypoxia-
exposed metastatic cells
The hypoxia-induced color changing cell lines were injected into mice mam-
mary fat pads (MFP) to form the primary tumor. Cells exposed to intra-
tumoral hypoxia would permanently cease expression of DsRed and begin
GFP expression. Metastatic colonies formed by such a primary tumor ex-
pressed DsRed or GFP, and could be grouped into two - those originating
from hypoxic cells (GFP+) and those from normoxic cells (DsRed+).
Figure 3.8 shows the results of the in vivo scheme of our image processing
script. Metastatic colony size distributions were obtained for individual
lungs (figure 3.8 C) and for the entire set used in the experiment (figure
3.8). It was observed that colonies were either DsRed+ or GFP+, indicating
monoclonal origin. A significant difference was observed between the colony
38
size distributions produced by DsRed+ and GFP+ cells. GFP+ cells were
observed to produce smaller colonies (Wilcoxon Rank-Sum test, P<0.01). A
sample image of a lung section which did not show significant difference at
the 1% level is provided, along with the probability density function in figure
3.9.
In work not yet published, it was observed that the DsRed+ cells prolif-
erated faster than GFP+ in vitro, which is borne out by the greater overall
metastatic load contribution by DsRed+ cells in lung sections. Furthermore,
The metastatic potential of GFP+ cells vs. DsRed+ cells was compared by
counting the colonies (manually, and by the algorithm presented here) and
normalizing them with the number of corresponding cells present in the tu-
mor at a given time point. It was observed that the GFP+ cells had a higher
metastatic potential.
The results were validated by manual counting of the number of colonies
in selected lungs and found to be consistent, as shown in figure 3.10 . Manual
counting is a time consuming process and took approximately 15-25 minutes
for each lung, as compared to 1-2 minutes it took for our MATLAB tool to
segment the same.
3.3.2 Colony size distributions from tail-vein injection of tu-
mor cells
Colony size distributions were obtained from experimental metastases result-
ing from a tail-vein injection of equal numbers of DsRed+ and GFP+ cells.
Five different mice were sacrificed and lung sections from each were analyzed
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to obtain colony size distributions. Furthermore, a set of four different lung
sections from the same mouse were also analyzed and the results shown in
figure 3.11. Compared to the orthotopic tumor injection experiment described
in the previous section, the lungs had lower overall metastatic load due to the
shorter time course of the experiment. No significant difference was obtained
in the probability distributions between DsRed+ and GFP+ cell lines.
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Figure 3.5: A: Colony size distributions over time. The Y-axis shows probability
density (relative probability) and the X-axis shows colony size in number of cells. Sig-
nificance was determined using the Wilcoxon rank-sum test. No significant difference
was seen between DsRed+/GFP+ colony distributions in control wells (not shown)
B: Colonies containing less than 50% of Ki-67+ cells. Treatment with Paclitaxel leads
to a higher fraction of colonies having low Ki-67 expression, which is quantitatively
captured by the image processing scheme. Significance was determined using 2-way
ANOVA. No significant difference was seen between DsRed+/GFP+ Ki-67 expression
in control wells (not shown)
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Figure 3.6: A: Microscope images showing untreated DsRed+ and pretreated GFP+
colonies. B: Microscope images showing DAPI (blue) and Ki-67 (red) staining. In
both cases, RFP+ colonies have a greater proportion of cells displaying the Ki-67 stain.
Several of the smaller GFP+ cells are devoid of Ki-67 stain entirely.
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Figure 3.7: Comparison of colony size distributions obtained from the MATLAB tool
described in this work and from a simple binarization/object counting step in ImageJ
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Figure 3.8: A: Composite lung image (RFP and GFP channels) B: Red and green
colony regions identified. C: Colony size distribution obtained by analyzing a single
lung section. D: Colony size probability distribution functions, mean and standard
deviation, from our complete set of 7 lung sections.
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Figure 3.9: A: Representative composite (RFP+GFP) image and segmented regions of
a lung that shows significant difference in colony sizes and size distribution by color.
B: Representative images of a lung that shows no significant difference in colony sizes
and size distribution.
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Figure 3.10: Validation of metastatic colony segmentation in vivo. Dashed lines show
99% confidence bounds. Red and Green colony counts are colored accordingly.
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Figure 3.11: A: Consolidated probability density functions of metastatic colony sizes
in lung sections of a single mouse injected with tumor cells in tail-vein. B: Probability
density functions averaged over five lung sections of a single mouse. Error bars
show standard deviation. C: Consolidated probability density functions of metastatic
colony sizes in lung sections of five mice injected with tumor cells in tail-vein D:
Probability density functions averaged over five lung sections of different mice. Error
bars show standard deviation.
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Chapter 4
Conclusion and Future Work
4.1 Conclusion
In this work we have provided an image-processing technique to obtain size
distributions of colonies in vitro and metastatic colonies in vivo. We have used
this method to investigate the effects of hypoxia on cancer cell metastasis,
and expect it to be useful for any system of cells tagged with fluorescent
markers. The method is fast and accurate even for dense colonies, and is ideal
for processing a large volume of slides or high-throughput applications.
With the growing popularity of fluorescent cells and transgenic reporter
mice, it is possible for the image-processing based methods described here to
provide detailed and granular information on cancer clonality and metastasis
both in vitro and in vivo. Such data is particularly important for developing
and validating accurate mathematical models of cancer metastasis, of which




The fixed-cell mode of the in vitro assay, can be modified to obtain the DNA
content of each cell by quantifying the DAPI signal received from each nucleus.
This would allow the cell-cycle phase (G1, G2, S) of the cell to be identified.
Image analysis based cell-cycle quantification has been demonstrated in earlier
work [47], and could add an interesting dimension to the colony-formation
assay described in this work by allowing experimenters to monitor changes
in expression of an immunostained protein-of-interest over different cell-cycle
phases.
The in vivo assay could be expanded to include measurements of immunos-
tained proteins-of-interest, such as Ki-67. While we did some preliminary
analyses, the variability of the Ki-67 stain obtained resulted in inaccurate
identification of regions of true staining as compared to background or aut-
ofluorescence in the CY5 channel.
It would be beneficial to improve segmentation accuracy and sensitivity
of the algorithm, especially for different metastatic organs, such as brain,
liver, lymph nodes. The liver suffers from high autofluorescence and hence
segmentation accuracy is lower here. Machine-learning techniques are a
promising avenue for improving segmentation, since we expect to produce
a large amount of fluorescence-microscopy images which may be used as
training sets. Extending this methodology to H&E stained sections would
widen the scope of this work significantly. While some efforts have been taken
in this direction, accurate segmentation remains challenging [48, 49].
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It would be interesting to use the imaging-based assay described here
(both in vitro and in vivo) to develop mathematical models of cancer metastasis.
Models of cancer metastasis have used either clinical data or low-resolution
metastatic data from mice, obtained using techniques such as BLI and others.
The limitations of both categories have been discussed earlier. Using tumor
growth, circulating-tumor-cell and colony size distribution data for our dual-
colored hypoxia system over different time points, a mathematical model
can be developed to characterize the experimental system. The response of
such a model to changes in its parameters could shed light on the differences
between hypoxic and normoxic cells. Finally, this method could be extended
to characterize any such fluorescent, dual-colored system [50, 51].
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Appendix A
Determining Role of TUBB6 on
Proliferation and Chemoresistance
Aside from work described previously in this document, we also investigated
the role of the human Tubulin Beta 6 Class V protein, coded by the TUBB6
gene, on tumor cell proliferation and chemoresistance. It was observed that
TUBB6 expression was independent of Hypoxia-Inducible-Factor 1 (HIF1)
and HIF2 expression, and did not significantly affect cell proliferation and
chemoresistance. The TUBB6 project is discussed briefly in this appendix.
Materials and Methods
Cell Culture
HS578T cells were cultured in Dulbecco’s Minimum Essential Media (DMEM)
(Sigma-Aldrich, St. Louis MI - USA) supplemented with 10% Fetal Bovine
Serum (FBS) and 1% penicillin-streptomycin (Invitrogen, Carlsbad) in a hu-
midified atmosphere of 5% CO2 at 37°C.
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Knockdown by CRISPR/Cas9
We used CRISPR/Cas9 to generate TUBB6 knockdowns in HS578T cells. Lenti-
CRISPR v2 plasmid used for generating a CRISPR-Cas9 endonuclease was a
gift from Feng Zhang (Broad Institute, Massachusetts Institute of Technology,
Cambridge, MA, obtained via Addgene (Addgene plasmid 52961)). Insert
oligonucleotides that include a guide RNA sequence were designed as shown
in Table A.1. After annealing, these oligos were inserted into the BsmBI
cloning site. After bacterial transformation and DNA purification, all plas-
mid constructs were confirmed by nucleotide sequencing. The LentiCRISPR
v2 plasmids and a non-targeted control were briefly co-transfected with 4
µg PsPAX2 and 1µg pMD2.G into a 10 cm dish of 293T cells using PolyJet
transfection reagent (SignaGen Laboratories, Rockville, MD) according to the
manufacturer’s instructions. Media was refreshed 16-24h following initial
transfection. Filtered viral supernatant was collected 48h post media change
and was added to SUM159 and MDA-MB-231 cells. Puromycin (0.5 µg/mL)
was added to the medium of cells transduced for selection. After selection,
cells were expanded and used for experiments.
Western Blots
Cells were lysed in IGEPAL CA-630 buffer (150mM NaCl, 1% IGEPAL CA-
630, 50 mM Tris-HCl, pH 8.0 and protease inhibitors) for 10 minutes on
ice, centrifuged for 10 min at 13,000 rpm at 4°C and the insoluble debris
were discarded. Whole cell lysates were fractionated by 12% SDS-PAGE
and transferred to nitrocellulose membrane (Bio-Rad). The membrane was
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incubated for 1 hour with 5% milk in TBS-T (Tris-buffered saline and 0.1%
Tween-20) and then incubated overnight with primary antibodies diluted in
blocking buffer. Antibodies against the following proteins were used: HIF-
1α (BD Biosciences, San Jose, CA), HIF-2α (Novus Biologicals, Littleton, CO),
TUBB6 (ProteinTech, Rosemont, IL), TUBB3 (ProteinTech), Actin (ProteinTech),
Phospho-Akt(Cell Signaling, Danvers, MA) and Akt (Cell Signaling). The
membrane was then washed and incubated with the corresponding HRP-
conjugated secondary antibody (Azure Biosystems, Dublin, CA) for 2 hours.
After washing, the chemiluminescence signal was detected on an AZURE
C300 using ECL (PerkinElmer, Waltham, MA).
Crystal Violet Proliferation Assay
To measure confluence, media was aspirated from cells in a well-plate, follow-
ing which 100µm crystal violet solution was added to each well. Cells were
incubated at room temperature under crystal violet solution for 10 minutes,
which was sufficient time for the cells to be stained. Confluence was measured
using the Cytation 5 Imaging Reader using a suitable threshold.
Results
TUBB6 knockdown in HS578T cells did not lead to significant
proliferation differences
Successful knockdown of the human β tubulin V (TUBB6) was verified at the
protein level by western blots shown in Figure A.1. Furthermore, knocking
down HIF1 and HIF2 expression did not affect TUBB6 expression at the
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Figure A.1: A: Western blot demonstrating successful TUBB6 knockdown in CRISPR
sites 3, 4, 5 and 7. Site 6 was rejected due to ineffective knockdown. Off-target
TUBB3 knockdown observed in sites 4 and 5. B: Repeat of blot A after 30 days shows
persistence of knockdown. Legend: P - Parental cell line, N - Non Target Control 2
(NTC2), 3-7 - TUBB6 CRISPR Knockdown sites, as shown in table A.1. C: TUBB6
expression is not governed by HIF1 or HIF2 expression or hypoxia as opposed to
TUBB3. Reduced TUBB3 expression is observed in the HIF1α/ HIF2α knockdowns.
Increased TUBB3 expression is also seen in parental and NTC cell lines exposed to
1%. Legend: P - Parental, N - Non Target Control 2. HIF1 and HIF2 knockdown sites
are labelled.
protein level (unlike TUBB3 expression, which is in agreement with literature)
. Proliferation studies were performed by measuring confluence increases
using crystal violet staining. Relative changes in confluence were obtained,
shown in figure A.2.
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Figure A.2: A: Images of crystal-violet stained cells showing proliferation over a
period of 48 hours. B: Relative increase in confluence over different knockdown cell
lines, obtained by thresholding the previous images. Legend: NTC2 - Non Target
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